Invex Therapeutics Ltd Dividend 2022

Invex Therapeutics Ltd (IXC) is a biopharmaceutical company, focused on the research and development of Exenatide as an efficacious treatment for neurological conditions derived from or involving raised intracranial pressure, such as Idiopathic Intracranial Hypertension (IIH), acute stroke, hydrocephalus, venous sinus thrombosis, brain tumours, meningitis, secondary pseudo tumour cerebri and traumatic brain injury.

Invex Therapeutics Ltd operators in Health Care sector and under industry of Pharmaceuticals. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

IXC Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found